Spectral appoints Anthony Bihl to Board of Directors

11-Mar-2008

Spectral Diagnostics Inc. announced that Mr. Anthony Bihl has been appointed to the Company's Board of Directors.

Mr. Bihl has more than 25 years of experience with diagnostic products, having held leadership roles in global healthcare businesses, including a broad base of operational and executive positions in large and medium multinational healthcare firms. Before his role as CEO of Siemens Medical Solutions Diagnostics, Mr. Bihl served in senior leadership roles at Bayer Healthcare Diagnostics, having held the roles of Senior VP of Finance and Administration and President, responsible for all aspects of this worldwide business Division. Prior to his tenure at Bayer, Mr. Bihl gained extensive operational experience through more than 20 years at E.I. DuPont Inc. His final role at DuPont was as Plant Manager for medical instrument manufacturing.

Mr. Bihl received a Bachelor's Degree in Business Administration from Pennsylvania State University, and is a member of the Board of Directors for Adnavance Technologies Inc.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances